Identification of EGFR Mutations by Immunohistochemistry with EGFR Mutation–Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma
Chi Hong Kim, Seung Hoon Kim, Sonya Youngju Park, Jinyoung Yoo, Sung Kyoung Kim, Hoon Kyo Kim
Cancer Res Treat. 2015;47(4):653-660. Published online 2015 Jan 30 DOI: https://doi.org/10.4143/crt.2014.118
|
Citations to this article as recorded by
MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers
Bianka Gurbi, Diána Brauswetter, Kinga Pénzes, Attila Varga, Tibor Krenács, Kornél Dános, Ede Birtalan, László Tamás, Miklós Csala
International Journal of Molecular Sciences.2023; 24(3): 2782. CrossRef Effects of EGFR gene mutation on stage 3A lung adenocarcinomas in the clinical decision-making process for mediastinal invasive staging
İsmail Ağababaoğlu, Özgür Ömer Yıldız, Hasan Ersöz, Gökçen Şimşek, Yavuz Selim Sanisoğlu, Nurettin Karaoğlanoğlu
Medical Science and Discovery.2022; 9(1): 44. CrossRef Dual NGS Comparative Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Non-Small Cell Lung Carcinoma (NSCLC)
Laura Buburuzan, Maria-Anca Zamfir (Irofei), Carmen Maria Ardeleanu, Alin Horatiu Muresan, Florina Vasilescu, Ariana Hudita, Marieta Costache, Bianca Galateanu, Alexandra Puscasu, Alexandru Filippi, Natalia Motas
Cancers.2022; 14(24): 6084. CrossRef Role of EGFR and HER-2/NEU Expression in Gall Bladder Carcinoma (GBC)
Chhanda Das, Madhumita Mukhopadhyay, Srijana Subba, Ashis Kumar Saha, Biswanath Mukhopadhyay
Journal of Laboratory Physicians.2021; 13(01): 029. CrossRef Application of the conventional and novel methods in testing EGFR variants for NSCLC patients in the last 10 years through different regions: a systematic review
Jasmina Obradovic, Jovana Todosijevic, Vladimir Jurisic
Molecular Biology Reports.2021; 48(4): 3593. CrossRef RETRACTED ARTICLE: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing
Georgios I. Laliotis, Evangelia Chavdoula, Maria D. Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh, Vollter Anastas, Keith A. Nair, Arturo Orlacchio, Vasiliki Taraslia, Ioannis Vlachos, Marina Capece, Artemis Hatzigeorgiou, Dario Pa
Nature Communications.2021;[Epub] CrossRef Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital
Moupali Ghosh, Madhumita Mukhopadhyay, Chhanda Das, Surojit Chatterjee, BidishaGhosh Naskar
Journal of Cancer Research and Therapeutics.2021; 17(6): 1389. CrossRef Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
Arutha Kulasinghe, Joanna Kapeleris, Carolina Cooper, Majid Ebrahimi Warkiani, Kenneth O’Byrne, Chamindie Punyadeera
Cancers.2019; 11(3): 380. CrossRef Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma
Dhoha Dhieb, Imen Belguith, Laura Capelli, Elisa Chiadini, Matteo Canale, Sara Bravaccini, Ilhem Yangui, Ons Boudawara, Rachid Jlidi, Tahya Boudawara, Daniele Calistri, Leila Ammar Keskes, Paola Ulivi
Cells.2019; 8(6): 514. CrossRef Intratumour heterogeneity of p53 expression; causes and consequences
Yuezhen Xue, Boris San Luis, David P Lane
The Journal of Pathology.2019; 249(3): 274. CrossRef Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non–Small-cell Lung Cancer
Edward Kim, Rebecca Feldman, Ignacio I. Wistuba
Clinical Lung Cancer.2018; 19(2): 105. CrossRef Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
Véronique Hofman, Sandra Lassalle, Coraline Bence, Elodie Long-Mira, Sacha Nahon-Estève, Simon Heeke, Virginie Lespinet-Fabre, Catherine Butori, Marius Ilié, Paul Hofman
Cancers.2018; 10(3): 70. CrossRef EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
Zohra Mraihi, Jihen Ben Amar, Hend Bouacha, Soumaya Rammeh, Lamia Hila
BMC Pulmonary Medicine.2018;[Epub] CrossRef Immunohistochemistry for EGFR Mutation Detection in Non–Small-Cell Lung Cancer
Nina Turnšek Hitij, Izidor Kern, Aleksander Sadikov, Lea Knez, Karmen Stanič, Matjaž Zwitter, Tanja Cufer
Clinical Lung Cancer.2017; 18(3): e187. CrossRef Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
Aeri Kim, Min Hye Jang, Soo Jung Lee, Young Kyung Bae
Journal of Breast Cancer.2017; 20(2): 150. CrossRef Detection of epidermal growth factor receptor mutations in lung adenocarcinoma cytological specimens by immunocytochemistry
Masami Yoshida, Tadasuke Nagatomo, Takafumi Ohnishi, Mayumi Kawashima, Akira Naitoh, Eiichi Morii
Molecular and Clinical Oncology.2017;[Epub] CrossRef Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methods
Hua-Lin Kao, Yi-Chen Yeh, Chin-Hsuan Lin, Wei-Fang Hsu, Wen-Yu Hsieh, Hsiang-Ling Ho, Teh-Ying Chou
Lung Cancer.2016; 101: 40. CrossRef LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients
Yu Jin Kim, Sungyoul Hong, Minjung Sung, Min Jeong Park, Kyungsoo Jung, Ka-Won Noh, Doo-Yi Oh, Mi-Sook Lee, Ensel Oh, Young Kee Shin, Yoon-La Choi
Oncotarget.2016; 7(50): 82876. CrossRef
|